Legal questions swirl around FDA's new expedited drug program, including who should sign off
- Posted on January 16, 2026
- By The Toronto Star
- 3 Views
Legal questions swirl around FDA's new expedited drug program, including who should sign off
WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the agency, stoking
